These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 27977507

  • 1. Neuroendocrine Gastroenteropancreatic Tumors: Where Are We?
    Ulla Rocha JL, Salgado A, Sardina Ferreiro R, Fernandez Catalina P, Gallardo E.
    Surg Laparosc Endosc Percutan Tech; 2017 Feb; 27(1):36-41. PubMed ID: 27977507
    [Abstract] [Full Text] [Related]

  • 2. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
    Ezziddin S, Attassi M, Yong-Hing CJ, Ahmadzadehfar H, Willinek W, Grünwald F, Guhlke S, Biersack HJ, Sabet A.
    J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
    [Abstract] [Full Text] [Related]

  • 3. Multimodality management, recurrence patterns, and long-term outcome of gastroenteropancreatic neuroendocrine neoplasms: Progress over 17 years.
    Desai GS, Pande P, Chhabra V, Shah RC, Jagannath P.
    Indian J Gastroenterol; 2019 Oct; 38(5):399-410. PubMed ID: 31802438
    [Abstract] [Full Text] [Related]

  • 4. Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.
    Hauck L, Bitzer M, Malek N, Plentz RR.
    Scand J Gastroenterol; 2016 Jan; 51(1):55-9. PubMed ID: 26137871
    [Abstract] [Full Text] [Related]

  • 5. Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.
    Keck KJ, Maxwell JE, Menda Y, Bellizzi A, Dillon J, O'Dorisio TM, Howe JR.
    Surgery; 2017 Jan; 161(1):272-279. PubMed ID: 27863780
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M, Zhao P, Shi X, Zhao A, Zhang L, Zhou L.
    BMC Endocr Disord; 2017 Jul 13; 17(1):39. PubMed ID: 28705205
    [Abstract] [Full Text] [Related]

  • 7. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
    Tierney JF, Chivukula SV, Wang X, Pappas SG, Schadde E, Hertl M, Poirier J, Keutgen XM.
    Surgery; 2019 Mar 13; 165(3):644-651. PubMed ID: 30366604
    [Abstract] [Full Text] [Related]

  • 8. Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals.
    Kıvrak Salim D, Bayram S, Gömceli İ, Çekin AH, Karaca M, Koçer M, Yıldız M.
    Turk J Gastroenterol; 2019 Oct 13; 30(10):910-916. PubMed ID: 31625933
    [Abstract] [Full Text] [Related]

  • 9. Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.
    Yoo C, Oh CR, Kim ST, Bae WK, Choi HJ, Oh DY, Lee MA, Ryoo BY.
    Cancer Res Treat; 2021 Apr 13; 53(2):291-300. PubMed ID: 33421978
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Mosquera C, Koutlas NJ, Fitzgerald TL.
    Eur J Surg Oncol; 2016 Oct 13; 42(10):1471-7. PubMed ID: 27528467
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
    Shi H, Zhang Q, Han C, Zhen D, Lin R.
    BMC Endocr Disord; 2018 Jul 28; 18(1):51. PubMed ID: 30055596
    [Abstract] [Full Text] [Related]

  • 15. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
    Lv Y, Han X, Xu XF, Ji Y, Zhou YH, Sun HC, Zhou J, Fan J, Lou WH, Huang C.
    BMC Cancer; 2019 Apr 08; 19(1):335. PubMed ID: 30961559
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.